Palo Alto, CA, United States of America

Jay A Chesavage

This inventor holds 28 USPTO granted patents and 3 published patent applications and 2 EPO patents, primarily in Medical Imaging. Top assignees: Otonexus Medical Technologies, Inc., Cisco Technology, Inc., Vasper Systems, LLC. Active years: 1991-2026.

USPTO Granted Patents = 28 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.1

ph-index = 8

Forward Citations = 348(Granted Patents)


Location History:

  • Seattle, CA (US) (2023)
  • Seattle, WA (US) (2023)
  • Palo Alto, CA (US) (1991 - 2024)

Company Filing History:


Years Active: 1991-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Medical Imaging
Infrared Otoscope
Optical Coherence Tomography
Acute Otitis Media
Bluetooth Communication
Neural Network
Fluidic Bladder
Ductile Membrane
Compartment Syndrome
Optical Combiner
AWG Filter
Clock Generation
28 patents (USPTO):Explore Patents

Title: Inventor Jay A Chesavage - Pioneering Innovations in Palo Alto

Introduction: Jay A Chesavage is a distinguished inventor based in Palo Alto, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Jay A Chesavage holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and ingenuity in the realm of innovation.

Career Highlights: With a career spanning over two decades, Jay A Chesavage has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of technology.

Collaborations: Throughout his career, Jay A Chesavage has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Jay A Chesavage's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…